Skip to main content

UNC Dermatology Clinical Trials Unit

Dermatology Research Registry
If you are interested in possibly participating in any of our current or future research studies, please sign up for our Dermatology Research Registry online or call 984-974-3682.
Your information will be kept confidential and will only be used to contact you about potential research studies. Your information will not be shared.

UNC Dermatology Clinical Trials Unit

The DCTU conducts research studies that evaluate and monitor the safety and efficacy of new treatments for various dermatologic conditions in children and adults.

Clinical Trials Currently Recruiting Patients

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST)

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines (RECLAIM)

Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa (TRuE-HS1)

A Study to Assess the Pharmacokinetics and Safety of Bimekizumab in Children and Adolescents With Moderate to Severe Hidradenitis Suppurativa

A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata (ALLEGRO-100)

The DCTU is located at:
410 Market Street, Suite 362
CB# 7715
Chapel Hill, NC 27516
Telephone: 984-974-3682
Fax: 984-974-3670